Passage Bio to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitGlobeNewsWire • Monday
Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should KnowZacks Investment Research • 03/07/24
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business HighlightsGlobeNewsWire • 03/04/24
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceGlobeNewsWire • 01/31/24
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic PrioritiesGlobeNewsWire • 12/20/23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsGlobeNewsWire • 11/13/23
Passage Bio to Present at Guggenheim's 5th Annual Inflammation, Neurology & Immunology ConferenceGlobeNewsWire • 10/30/23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business HighlightsGlobeNewsWire • 08/07/23
Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 StudyGlobeNewsWire • 08/07/23
Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare ConferenceGlobeNewsWire • 06/05/23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business HighlightsGlobeNewsWire • 05/11/23
Passage Bio to Present at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing SummitGlobeNewsWire • 04/17/23
Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease DaysGlobeNewsWire • 03/27/23
Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business HighlightsGlobeNewsWire • 03/06/23